Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KIRREL3 antisense RNA 3 (KIRREL3-AS3) is classified as a long non-coding RNA (lncRNA), with alternative names including PRR10, NCRNA00288, and Proline-rich protein 10[7][3]. While there are references to putative protein products and catalogued recombinant proteins corresponding to KIRREL3-AS3, the predominant classification across genomic and gene annotation resources is that of a non-protein coding RNA[7][3]. Its precise biological function, molecular activity, and involvement in disease remain uncharacterized, and there is currently no evidence to support its role as a conventional therapeutic target such as a receptor, enzyme, transporter, or transcription factor[7][3][4]. It is distinct from the KIRREL3 gene, which encodes the Kin of IRRE-like protein 3, a well-characterized protein involved in synapse formation and kidney function[1]. The function of KIRREL3-AS3 is not well understood, and there are no documented interacting drugs, mechanism of action, or validated biomarker applications in the current literature or databases[7][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KIRREL3 antisense RNA 3 (KIRREL3-AS3).